1. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histo-
pathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003;14:47–62. 2. Scully C, Felix DH. Oral Medicine – update for the dental practitioner: oral white patches. Br Dent J 2005;199:565–72. 3. Scheifele C, Reichart PA, Dietrich T. Low prevalence of oral leukoplakia in a representative sample of the US population. Oral Oncol 2003;39:619–25. 4. Bornstein MM, Luond-Valeskeviciute I, Altermatt HJ, Stauffer E, Buser D. Oral mucosal lesions diagnosed in a stomatology service. An examination of clinico- pathological findings from the year (German). Schweiz Monatsschr Zahnmed 2003;2006(116):468–75. 5. Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol 2003;39:770–80. 6. Dundar N, Ilhan Kal B. Oral mucosal conditions and risk factors among elderly in a Turkish school of dentistry. Gerontology 2007;53:165–72. 7. Lodi G, Porter S. Management of potentially malignant disorders: evidence and critique. J Oral Pathol Med 2008;37:63–9. 8. Ferreira LL, Biasoli ÉR, Bernabé DG, Nunes CM, Miyahara GI. Plasma HPV DNA is detectable in oral leukoplakia patients. Pathol. Res. Pract. 2017 Jul;213(7):759-765. 9. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809–20. 10. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009 Apr-May;45(4-5):317-23. 11. Meyer MS, Joshipura K, Giovannucci E, Michaud DS. A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control 2008;19:895–907. 12. Newman M, Caton J, Gunsolly J. Evidence-based periodontology. Ann Periodontol. 2003;8:1 13. Splieth CH, Sumnig W, Bessel F, John U, Kocher T. Prevalence of oral mucosal lesions in a representative population. Quintessence Int 2007;38:23–9. 14. Meisel P, Dau M, Sümnig W, Holtfreter B, Houshmand M, Nauck M, et al. The association between glycemia, serum lipoproteins and the Risk of oral leukoplakia: the population-based study SHIP. Diabetes Care 2010;33:1230–2.